These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 8707016)

  • 1. Grading, staging and scoring of left-ventricular hypertrophy, left-ventricular dilatation, asymptomatic left-ventricular dysfunction and chronic heart failure.
    Field ML; Coats AJ
    Eur Heart J; 1999 Sep; 20(17):1224-33. PubMed ID: 10454974
    [No Abstract]   [Full Text] [Related]  

  • 2. Left ventricular hypertrophy: beyond the image and defining the human cardiac phenotype in hypertension.
    Jennings GL; McMullen JR
    J Hypertens; 2007 May; 25(5):941-7. PubMed ID: 17414655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphofunctional parameters of the left heart ventricle in nephrogenic arterial hypertension].
    Ianbaeva KhI; Kaipov AA
    Klin Med (Mosk); 1995; 73(5):74. PubMed ID: 8815294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular hypertrabeculation/noncompaction requires comprehensive cardiological and neurological examinations.
    Stöllberger C; Blazek G; Finsterer J
    Hum Pathol; 2006 Jan; 37(1):122; author reply 123. PubMed ID: 16360427
    [No Abstract]   [Full Text] [Related]  

  • 6. Decrease of left ventricular mass is a clinically valuable intermediate end-point of antihypertensive treatment.
    Agabiti-Rosei E
    Blood Press Suppl; 1997; 2():13-5. PubMed ID: 9495620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of exercise echocardiography in patients with left ventricular hypertrophy.
    Bella JN
    Am J Hypertens; 2010 Jul; 23(7):706. PubMed ID: 20559291
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial hypertension, left ventricular geometry and QT dispersion in a middle-aged Estonian female population.
    Shipilova T; Pshenichnikov I; Kaik J; Volozh O; Abina J; Kalev M; Lass J; Karai D
    Blood Press; 2003; 12(1):12-8. PubMed ID: 12699130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsolved issues of left ventricular hypertrabeculation/noncompaction.
    Finsterer J; Stöllberger C
    Eur J Echocardiogr; 2006 Jan; 7(1):5-6; author reply 7-8. PubMed ID: 16289927
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arrhythmia risk in left ventricular hypertrophy].
    Perings C; Hennersdorf M; Vester EG; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():36-43. PubMed ID: 10810783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Three-dimensional echocardiography in assessment of left ventricular myocardial mass: comparison of the results of one-dimensional, two-dimensional echocardiography and MR tomography].
    Saidova MA; Stukalova OV; Sinitsyn VE; Sergakova LM; Ataullakhanova DM; Botvina IuV
    Ter Arkh; 2005; 77(4):11-4. PubMed ID: 15938525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
    Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
    Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy, cardiac imaging and cardiac electric activity.
    Gatzka CD
    J Hypertens; 2002 Nov; 20(11):2153-6. PubMed ID: 12409952
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Method errors or unexplained biological information?
    Chirinos JA; Gillebert TC; Segers P; De Buyzere ML; Kronmal R; Raja MW; De Bacquer D; St John-Sutton M; Rietzschel ER
    Hypertension; 2011 Mar; 57(3):e9-10. PubMed ID: 21425520
    [No Abstract]   [Full Text] [Related]  

  • 18. Invited commentary.
    Doenst T
    Ann Thorac Surg; 2012 Nov; 94(5):1517-8. PubMed ID: 23098933
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphofunctional features of left ventricular hypertrophy].
    Ghione S; Genovesi-Ebert A; Marabotti C
    G Ital Cardiol; 1995 Dec; 25(12):1659-68. PubMed ID: 8707016
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.